MARKET

NTRA

NTRA

Natera Inc
NASDAQ
124.16
+3.20
+2.65%
After Hours: 124.88 +0.72 +0.58% 19:49 11/01 EDT
OPEN
120.80
PREV CLOSE
120.96
HIGH
124.29
LOW
120.80
VOLUME
1.27M
TURNOVER
--
52 WEEK HIGH
133.54
52 WEEK LOW
36.90
MARKET CAP
15.36B
P/E (TTM)
-50.3651
1D
5D
1M
3M
1Y
5Y
1D
Press Release: Natera to Report its Third Quarter 2024 Results on November 12, 2024
Dow Jones · 1d ago
Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds
Seeking Alpha · 1d ago
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Benzinga · 1d ago
Natera Is Maintained at Outperform by Bernstein
Dow Jones · 2d ago
Bernstein Maintains Outperform on Natera, Raises Price Target to $135
Benzinga · 2d ago
NATERA INC <NTRA.O>: BERNSTEIN RAISES TARGET PRICE TO $135 FROM $125
Reuters · 3d ago
Natera price target raised to $135 from $125 at Bernstein
TipRanks · 3d ago
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
NASDAQ · 3d ago
More
About NTRA
Natera, Inc. is a diagnostics company, which is focused on the development and commercialization of molecular testing services, applying its technology in the fields of women’s health, oncology and organ health. Its cell-free deoxyribonucleic acid (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The Company's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening, Spectrum Preimplantation Genetics, Anora Miscarriage Test, Empower, and Prospera. The Company also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology. Its NIPT screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother.

Webull offers Natera Inc stock information, including NASDAQ: NTRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTRA stock methods without spending real money on the virtual paper trading platform.